L. Galletto

发表

Breast Cancer Estrogen and Progesterone Receptors: Associations with Patients' Clinical and Epidemiologic Characteristics

M. Indelli, A. Liberati, F. Parazzini, 1991, Tumori.

ICON2: randomised trial of single-agent carboplatin against three-drug combination of CAP (cyclophosphamide, doxorubicin, and cisplatin) in women with ovarian cancer

M. Buyse, E. Dreher, Torri, 1998, The Lancet.

Are Surveillance Procedures of Clinical Benefit for Patients Treated for Ovarian Cancer?: A Retrospective Italian Multicentric Study

A. Gadducci, E. Sartori, F. Landoni, 2009, International Journal of Gynecologic Cancer.

Adjuvant treatment and survival in obese women with endometrial cancer: an international collaborative study.

P. Zola, L. Galletto, V. V. von Gruenigen, 2008, American journal of obstetrics and gynecology.

Variation in gynecological oncology follow-up practice: Attributable to cancer centers or to patient characteristics? A Piedmont Regional Oncology Network Study

D. Katsaros, G. Apolone, P. Zola, 2011 .

Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. The GIVIO Investigators.

M. Indelli, V. Torri, A. Liberati, 1994, JAMA.

[Burns in pregnancy].

P. Sismondi, L. Galletto, M. Bormioli, 1979, Minerva ginecologica.

Could follow-up different modalities play a role in asymptomatic cervical cancer relapses diagnosis? An Italian multicenter retrospective analysis.

A. Gadducci, E. Sartori, F. Landoni, 2007, Gynecologic oncology.

Could Different Follow-Up Modalities Play a Role in the Diagnosis of Asymptomatic Endometrial Cancer Relapses?: An Italian Multicentric Retrospective Analysis

A. Gadducci, E. Sartori, F. Landoni, 2012, International Journal of Gynecologic Cancer.

Breast self examination survey carried out at a cancer prevention center serving a province.

L. Galletto, M. Viglietta, S. Pelizzari, 1983, European journal of gynaecological oncology.

Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, oestrogen-receptor positive breast cancer patients. An update at 7 years of the 1st GROCTA (Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group) trial.

P. Sismondi, I. Nenci, F. Boccardo, 1992, European journal of cancer.

Variation in gynecological oncology follow-up practice: attributable to cancer centers or to patient characteristics? A Piedmont Regional Oncology Network Study.

D. Katsaros, G. Apolone, G. Ciccone, 2011, Tumori.